The Role of Large Animal Studies in Cardiac Regenerative Therapy Concise Review of Translational Stem Cell Research.
10.4070/kcj.2013.43.8.511
- Author:
Sung Uk KWON
1
;
Alan C YEUNG
;
Fumiaki IKENO
Author Information
1. Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA. fikeno@stanford.edu
- Publication Type:Clinical Trial ; Review
- Keywords:
Translational research;
Clinical trial;
Stem cells;
Heart diseases;
Regenerative medicine
- MeSH:
Animals;
Cardiovascular Diseases;
Heart;
Heart Diseases;
Models, Animal;
Regenerative Medicine;
Stem Cell Research;
Stem Cells;
Tissue Therapy;
Translational Medical Research
- From:Korean Circulation Journal
2013;43(8):511-518
- CountryRepublic of Korea
- Language:English
-
Abstract:
Animal models have long been developed for cardiovascular research. These animal models have been helpful in understanding disease, discovering potential therapeutics, and predicting efficacy. Despite many efforts, however, translational study has been underestimated. Recently, investigations have identified stem cell treatment as a potentially promising cell therapy for regenerative medicine, largely because of the stem cell's ability to differentiate into many functional cell types. Stem cells promise a new era of cell-based therapy for salvaging the heart. However, stem cells have the potential risk of tumor formation. These properties of stem cells are considered a major concern over the efficacy of cell therapy. The translational/preclinical study of stem cells is essential but only at the beginning stages. What types of heart disease are indicated for stem cell therapy, what type of stem cell, what type of animal model, how do we deliver stem cells, and how do we improve heart function? These may be the key issues that the settlement of which would facilitate the transition of stem cell research from bench to bedside. In this review article, we discuss state-of-the-art technology in stem cell therapies for cardiovascular diseases.
